Beijing Yibai Technology Co., Ltd. (Yibai Technology) is China’s leading provider of medical digital transformation services. With the self-developed pharmaceutical marketing SaaS cloud service, Yibai can quickly generate an exclusive marketing digital transformation platform for pharmaceutical companies, and provide a full-scenario one-stop SaaS cloud service to help pharmaceutical companies enter the digitalization of marketing. At present, Yibai Technology has successfully served more than 400 domestic and foreign head pharmaceutical companies, including Pfizer, Janssen, GSK, Sumitomo, Poco, Tanabe, Daiichi Sankyo, China Resources Pharmaceuticals, CSPC, Qilu, Tasly, Hokuriku, Xinlitai, Zhenbaodao, Kelun, covering from online department meetings, corporate conferences, open classes to case collection, questionnaire surveys, live surgery, surgery demonstrations, telemedicine, doctor education, store assistant training and other pharmaceutical occasions. More than 30 application scenarios for marketing help pharmaceutical companies obtain content, data, and users on their own dedicated platforms.

Exited

Founded Date

2014

Investment Round

Series A

Investment Date

2018

Latest Round

Series A